Serine Bioproduction Engineering Service

Serine is a non-essential amino acid with broad applications in pharmaceuticals, functional foods, and cosmetics. Microbial biosynthesis of Serine is preferred over chemical synthesis for its clean process and high stereo-purity. However, production is severely limited by a low fermentation yield . The Serine pathway is tightly regulated by end-product inhibition, where accumulated Serine significantly slows down the entire metabolic flow. This leads to the problem of high cost for extraction and purification because low-titer broths necessitate extensive and energy-consuming downstream processing to isolate the final product. Enhancing the Serine production flux is the critical bottleneck.

CD Biosynsis offers a synthetic biology service focused on engineering Escherichia coli for high-titer Serine production. Our core strategy involves modification of serine synthase in Escherichia coli . Serine is synthesized from the glycolysis intermediate 3-Phosphoglycerate (3-PGA) via Phosphoglycerate Dehydrogenase (SerA), Phosphoserine Aminotransferase (SerC), and Phosphoserine Phosphatase (SerB). We specifically target the rate-limiting enzyme Serine Synthase (SerA) and introduce mutations to enhance its intrinsic catalytic rate and robustness. This is coupled with relief of feedback inhibition . SerA is strongly inhibited by Serine itself. We employ site-directed mutagenesis to alter the allosteric sites of SerA to eliminate or drastically reduce this feedback inhibition. Additionally, we optimize upstream glycolysis flux and reduce the consumption of Serine by competing pathways (e.g., conversion to Glycine). This integrated approach aims to create a highly robust, feedback-resistant metabolic flow, resulting in a high-concentration Serine broth that significantly lowers the overall manufacturing cost.

Pain Points

Achieving cost-effective, high-yield Serine production faces these key challenges:

• Low Fermentation Yield: The activity of Phosphoglycerate Dehydrogenase (SerA), the first committed step in Serine synthesis, is rapidly inhibited by its end-product, Serine, leading to a self-limiting low yield .
• High Cost for Extraction and Purification: Low Serine concentration in the fermentation broth means large volumes must be processed for crystallization and purification, increasing energy, solvent, and labor costs.
• Pathway Leakage: Serine is a precursor for other essential molecules (e.g., Glycine, cysteine), resulting in carbon flux diversion that reduces the final Serine accumulation.
• Precursor Imbalance: The supply of the initial precursor, 3-PGA, from glycolysis must be precisely balanced with growth demands to prevent a bottleneck at the entry point of the pathway.

A successful solution must remove the primary regulatory roadblock (feedback inhibition) and efficiently funnel carbon flow towards Serine accumulation.

Solutions

CD Biosynsis utilizes advanced metabolic engineering to optimize Serine production in E. coli:

Modification of Serine Synthase in E. coli

           

We overexpress the entire Serine biosynthesis operon (SerA, SerB, SerC) to increase pathway enzyme quantity, focusing on SerA for kinetic improvement.

Relief of Feedback Inhibition

We perform site-directed mutagenesis on SerA to abolish allosteric binding of Serine, creating a robust enzyme variant (SerA^mut) that is insensitive to high Serine concentration.

Competing Pathway Blockade

We knock out or downregulate downstream pathways that consume Serine, such as the Serine Hydroxymethyltransferase (GlyA) pathway to Glycine and Cysteine synthesis.

Glycolysis Flux Optimization

We modify regulatory genes to increase the flow of 3-PGA from the EMP pathway into the Serine synthesis route, eliminating precursor limitation.

This systematic approach overcomes the primary regulatory barriers and maximizes carbon efficiency towards Serine production.

Advantages

Our Serine engineering service is dedicated to pursuing the following production goals:

Dramatically Increased Titer

Removal of feedback inhibition allows Serine to accumulate to much higher concentrations than the native host can tolerate.

Significant Cost Reduction

Higher titer broth reduces the volume processed and simplifies purification steps, lowering the total manufacturing cost.

High Carbon Yield

Blockade of competing pathways ensures that a maximum percentage of the carbon source (e.g., glucose) is converted into the Serine product.

High Stereochemical Purity

Biosynthesis naturally produces the desired L-Serine isomer , avoiding the costly chiral resolution step required by chemical synthesis.

E. coli Robustness and Scalability Icon

The engineered E. coli strain is ready for large-scale fed-batch fermentation , providing a cost-effective and proven production platform.

We provide a reliable and efficient manufacturing platform for pharmaceutical-grade L-Serine.

Process

Our Serine strain engineering service follows a rigorous, multi-stage research workflow:

• SerA Mutagenesis: Identify and introduce specific mutations (e.g., R433P, G287S) into the SerA gene to abolish Serine feedback inhibition .
• Pathway Overexpression: Integrate and co-express the mutated SerA, SerB, and SerC at high copy numbers under a strong constitutive promoter to maximize pathway capacity.
• Competing Pathway Blockade: Use gene deletion (e.g., CRISPR/Cas systems) to knock out GlyA (the Serine-to-Glycine enzyme) and other minor Serine consuming enzymes.
• Precursor Flux Enhancement: Modify upstream genes (e.g., PGI or TPI) to increase the flow of 3-PGA into the Serine pathway.
• Functional and Titer Assays: Validate the engineered strain in fed-batch culture, measuring the final Serine concentration and carbon yield .
• Result Report Output: Compile a detailed Experimental Report including vector maps, SerA mutant sequences, and fermentation metrics (final titer and yield) , supporting industrial scale-up.

Technical communication is maintained throughout the process, focusing on timely feedback regarding Serine yield and pathway efficiency.

Explore the potential for a stable, high-yield Serine supply. CD Biosynsis provides customized strain and pathway engineering solutions:

• Detailed Feedback Resistance and Titer Report , demonstrating the functional change in SerA^mut and its impact on yield.
• Consultation on optimized fermentation conditions (e.g., pH and temperature) to maintain high Serine production rates.
• Experimental reports include complete raw data on Serine productivity (g/L/h) and final product yield (g/g glucose) , essential for cost-reduction analysis.